20010720
 Lilly and Others To Slash Prices Of Drugs for TB That Defies Cure   By By Gautam Naik and Rachel Zimmerman, The Wall Street Journal,  Jul 20, 2001  The discounted drugs are used for treating multidrug-resistant tuberculosis -- deadly strains that are spreading in various countries, including in eastern and western Europe and the U.S. The medicines, including drugs manufactured by Eli Lilly & Co., Indianapolis; Jacobus Pharmaceutical, Princeton, N.J., and several generics makers, previously cost as much as $19,000 for the full, two-year course of treatment. Now, said Rajesh Gupta, a scientist with the World Health Organization, the full course costs $1,800 or less.   
